The contamination or incorrect measurement of raw materials
used in the manufacture of pharmaceutical and healthcare
products poses a significant risk to patient safety. As a result,
regulatory requirements for raw material identification and QA/
QC manufacturing process have become increasingly stringent
and manufacturers are faced with the challenges of meeting these
requirements while simultaneously trying to improve productivity,
reduce costs and deliver innovative products to market. Suzanne
Schreyer, Sr. Applications Scientist at Rigaku Analytical Devices,
focuses on the Raman advantage for pharmaceutical manufacturing.
https://international-pharma.com/wp-content/uploads/2016/07/Man-1-Safe-Fast.pdf
Current Edition
Current Edition
Subsection - CDMO
Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.
Continue readingSubsection - Injectables
Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.
Continue readingSubsection - Neurodegenerative Diseases
Exploring emerging approaches to neurodegenerative disease research and treatment.
Continue readingSubsection - Nasal & Pulmonary
Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.
Continue reading
Safe, Fast and Compliant: The Raman Advantage for Pharmaceutical Manufacturing
